Speaker
Director, Microbial Process Operations, Merck & Co
Emily Greenhagen, Director, Microbial Process Operations at Merck & Co, spoke at 6th Applied Biocatalysis & Enzyme Engineering Summit (Boston, United States of America, 30 Sept – 1 Oct 2026) in the session “Unlocking Scalable Macrocyclic Peptide Production Through Integrated Biocatalysis”.
30 Sept – 1 Oct 2026Boston, United States of America
Researcher, DTU BRIGHT The Novo Nordisk Foundation Biotechnology Research Institute, Novo Nordisk
Distinguished Principal Scientist, National Renewable Energy Laboratory (NREL)
Principal Scientist, Cyrus Biotechnology Inc.
Chief Scientific Officer & Co-Founder, Imperagen
Chair of Chemistry, University of Texas at Dallas
Professor of Chemistry, Princeton University
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Emily Greenhagen, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].